The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

(MENAFN) Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

I think [this technology] will be among the most important things.' Similar experimental mRNA cancer vaccines have been in development since the technology was advanced during the Covid pandemic.

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the Markey Cancer Center ...